Recommendation based on the findings from the Phase 3 QUASAR programme in ulcerative colitis 1. Beerse, Belgium (28 February 2025) - Johnson & Johnson today announced that the Com ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...

FAECAL microbiota transplantation (FMT) shows promise in treating ulcerative colitis (UC), with specific gut microbial ...

Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever ...

The IVDR certification allows the company to pursue market expansion within Europe's in vitro diagnostic market.

Scarring is expected after most operations, but surgical adhesions present a unique challenge for patients and surgeons.

• Azathioprine and 6-mercaptopurine seem to be more effective than placebo (fake pills) for the long-term treatment of ulcerative colitis, which is an inflammatory disorder of the large bowel. • There ...

Scientists from the Lebanese American University investigated the role of acetyl-CoA synthetase short chain family member 2 (ACSS2) in inflammatory bowel disease, including ulcerative colitis and ...

Daniela Soto, 25, lives in Los Angeles and was diagnosed with ulcerative colitis (UC) when she was just 21. If you don’t know ...

A clinical study is underway that is testing whether an investigational medicine is safe and whether it may work to help ...

The tests identify specific foods that may trigger inflammation in patients with Crohn's disease and ulcerative colitis.